On Wednesday, Shares of Intrexon Corp (NYSE:XON), gained 5.76% to $51.75.
Soligenix, declared highlights, and financial results for the second quarter and six months ended June 30, 2015.
Christopher J. Schaber, PhD, President, and Chief Executive Officer of Soligenix stated, “During the quarter we continued enrollment of additional patients in the SGX942 Phase 2 clinical trial in oral mucositis and expect data during the second half of 2015. We reached a partnershipwith the National Organization for Rare Disorders (NORD) and the Cutaneous Lymphoma Foundation (CLF) to support recruitment into the SGX301 pivotal Phase 3 cutaneous T-cell lymphoma (CTCL) clinical study set to start in the second half of 2015. We were also happy that the European Commission granted orphan designation for SGX301 for the treatment of CTCL. Within our Biodefense business segment, we initiated a development agreement with Emergent BioSolutions Inc. to implement a commercially viable, scalable production process for our RiVax drug substance. We further expanded our ThermoVax technology platform via a partnershipwith the University of Hawaiʻi at Manoa and Hawaii Biotech, Inc. to develop a heat stable Ebola vaccine.
Dr. Schaber continued, “Following the end of the second quarter, we raised our access to capital by entering into a $10 million equity purchase agreement with accredited investors. This funding, to be used at our sole discretion, has the potential to fund ongoing development initiatives for our late-stage product candidates, counting the Phase 3 CTCL clinical study. Our cash position for the second quarter ended June 30, 2015 was $4.0 million as compared to $5.0 million at March 31, 2015. I look forward to providing further updates throughout the year.”
Soligenix is a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. Soligenix has an exclusive worldwide partnership with Intrexon Corporation (XON) focused on the joint development of SGX101 for the treatment for melioidosis.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components.
Shares of Scripps Networks Interactive, Inc. (NYSE:SNI), inclined 0.20% to $58.92, during its last trading session.
Scripps Networks Interactive stated second-quarter 2015 operating results.
Merged revenues for the quarter raised $24.0 million, or 3.4 percent, to $732.1 million from the preceding-year period. Results for the three-month period ended June 30 comprise advertising revenue of $502.9 million, up $5.9 million, or 1.2 percent, over last year and associate fee revenue of $215.2 million, up $17.2 million, or 8.7 percent, year over year.
Cost of services and selling, general and administrative expenses for the quarter reduced $15.3 million, or 3.9 percent, to $373.6 million from the preceding-year period, driven by a reduction in ongoing employee costs as a result of the restructuring program executed in the fourth quarter of 2014. Comprised of in the second quarter of 2015 were:
- $5.3 million of costs related to the formerly declared restructuring program; and
- $4.2 million of transaction and integration expenses related to the TVN acquisition.
- Comprised of in the second quarter of 2014 were:
- $9.7 million of costs related to the termination of certain third-party service provider contracts.
Not taking into account the impact of these items in their respective periods, cost of services and selling, general and administrative expenses would have reduced $15.1 million, or 4.0 percent, to $364.0 million.
Total segment profit raised $39.2 million, or 12.3 percent, to $358.5 million, reflecting the lower selling, general and administrative expenses from the formerly declared restructuring program.
Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America.
At the end of Wednesday’s trade, Shares of RetailMeNot Inc (NASDAQ:SALE), gained 6.40% to $9.14.
RetailMeNot, released the findings of an August 2015 study it commissioned from Forrester Consulting that looks at how smartphones and apps are changing the retail landscape and how retailers should respond to engage shoppers.
The findings of the study are based on consumer surveys and retailer interviews. One major insight the study provides is that while today’s consumers overwhelmingly prefer to access the Internet on their mobile devices, only 30% use retailer applications to purchase products.
This mobile revolution in retail is not lost on marketers. Retailers increasingly understand the importance of engaging with shoppers in these mobile moments. However, retailers struggle to get consumers to download and use their apps. In fact, 60% of consumers have two or fewer retailer apps on their phones, and 21% have none.
RetailMeNot, Inc. operates a digital coupon marketplace. Its marketplace connects consumers with retailers and brands. The company owns and operates digital coupon Websites, counting RetailMeNot.com in the United States; VoucherCodes.co.uk in the United Kingdom; and Bons-de-Reduction.com, Poulpeo.com, and Ma-Reduc.com in France.
Finally, Westar Energy Inc (NYSE:WR), ended its last trade with 1.46% gain, and closed at $38.86.
Westar Energy, declared earnings of $64 million, or $0.47 per share, for the second quarter 2015 contrast with earnings of $53 million, or $0.41 per share, for the second quarter 2014. Earnings for the six months ended June 30, 2015 were $115 million, or $0.85 per share, contrast with $122 million, or $0.95 per share, for the same period in 2014.
Higher net income for the three months ended June 30, 2015 was driven by lower operating and maintenance costs at the company`s power plants and higher COLI income. The lower expenses and higher COLI income were offset by a decrease in retail sales due largely to mild weather contrast with last year and a $3 million estimated refund obligation for transmission revenue.
Lower net income for the six months ended June 30, 2015 reflects mild weather, which reduced both energy marketing margins and retail energy sales, and a $9 million estimated refund obligation for transmission revenue. Lower operating expenses and receipt of COLI income partially offset the lower revenues.
Westar Energy, Inc., an electric utility company, generates, transmits, and distributes electricity in Kansas. The company has 7,200 megawatts of electric generation capacity producing electricity through various fuel types, counting coal, uranium, natural gas, diesel, wind, and landfill gas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
